Aspire Biopharma Stock Forecast

Buy candidate since Jul 30, 2026 Loss -2.98%

The Aspire Biopharma, Inc. stock price fell by -2.98% on the last day (Friday, 31st Jul 2026) from $6.72 to $6.52. During the last trading day the stock fluctuated 5.35% from a day low at $6.36 to a day high of $6.70. The price has risen in 6 of the last 10 days and is up by 4.49% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -4 thousand shares and in total, 9 thousand shares were bought and sold for approximately $61.25 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 19.22% during the next 3 months and, with a 90% probability hold a price between $6.69 and $9.43 at the end of this 3-month period.

ASBP Signals & Forecast

The Aspire Biopharma, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $6.79. On a fall, the stock will find some support from the long-term average at approximately $6.29. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 30, 2026, and so far it has fallen -2.98%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Aspire Biopharma, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.65 and $5.55. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Aspire Biopharma, Inc. finds support just below today's level at $5.65. If this is broken, then the next support from accumulated volume will be at $5.55 and $4.96.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.340 between high and low, or 5.35%. For the last week the stock has had daily average volatility of 17.08%.

Our recommended stop-loss: $6.19 (-5.03%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (ASBP) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Aspire Biopharma, Inc. to open at $6.53, and during the day (based on 14 day Average True Range), to move between $6.12 and $6.92, which gives a possible trading interval of +/-$0.80 (+/-13.09%) up or down from last closing price. If Aspire Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 13.09% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $6.58 (0.92%) than the support at $5.65 (13.34%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Aspire Biopharma, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Aspire Biopharma, Inc. stock to perform well in the short-term.

Current score: 1.114 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $6.53 ( 0.102%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk